Taigo M. Kato

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 213 publications

Editorial Comment From Dr. Kato to Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell Carcinoma.

Editorial Comment From Dr. Kato to Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell Carcinoma.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: June 28, 2026

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Journal: Japanese journal of clinical oncology

Published: May 27, 2026

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Journal: Japanese journal of clinical oncology

Published: May 11, 2026

Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview.

Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview.

Journal: International journal of clinical oncology

Published: May 02, 2026

Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.

Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.

Journal: Biomarker research

Published: April 29, 2026

Successful Closure of Persistent Urinary Fistula After High-Grade Renal Trauma Using N-Butyl-2-Cyanoacrylate: A Case Report.

Successful Closure of Persistent Urinary Fistula After High-Grade Renal Trauma Using N-Butyl-2-Cyanoacrylate: A Case Report.

Journal: IJU case reports

Published: April 28, 2026

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Journal: Scientific reports

Published: April 02, 2026

Retroperitoneal Robot-Assisted Nephroureterectomy: Technical Description and Single Center Experience.

Retroperitoneal Robot-Assisted Nephroureterectomy: Technical Description and Single Center Experience.

Journal: Asian journal of endoscopic surgery

Published: March 31, 2026

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Journal: Cancer treatment and research communications

Published: March 26, 2026

Search for K_{L}→π^{0}π^{0}γγ and K_{L}→π^{0}π^{0}X where X→γγ at the KOTO Experiment.

Search for K_{L}→π^{0}π^{0}γγ and K_{L}→π^{0}π^{0}X where X→γγ at the KOTO Experiment.

Journal: Physical review letters

Published: March 22, 2026

Allowable robot-related material cost as a contribution margin threshold for financial sustainability of robot-assisted urologic surgery.

Allowable robot-related material cost as a contribution margin threshold for financial sustainability of robot-assisted urologic surgery.

Journal: Journal of robotic surgery

Published: February 15, 2026

[18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.

[18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 13, 2026

Showing 1-12 of 213

Last Updated: 09/26/2026